Luca Saba on Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification
Luca Saba, Dean of School of Medicine at the University of Cagliari, shared a post on LinekedIn:
”New publication in JAMA Cardiology
Together with Peter Libby, we explore a long-standing assumption in stroke medicine that may need revision.
For decades, carotid artery disease has been considered responsible for only a small fraction of ischemic strokes, typically those associated with high-grade stenosis.
This view shaped both clinical guidelines and epidemiologic data.
We argue that this framework introduces a systematic bias in how stroke risk is assessed and attributed.
A significant number of ischemic strokes may in fact originate from nonstenotic but biologically high-risk carotid plaques: lesions characterized by hemorrhage, inflammation, or surface ulceration, which traditional stenosis-based classifications fail to capture.
This conceptual bias affects not only clinical decision-making, potentially excluding at-risk patients from early intervention, but also epidemiologic estimates and public health planning, by underestimating the true contribution of carotid atherosclerosis to the global burden of stroke.
We propose that plaque-centered risk models, such as the recently introduced Carotid Plaque–RADS, can complement traditional stenosis thresholds by integrating compositional and morphological information from CT, MRI, and ultrasound.
This work calls for a shift from a purely geometric definition of disease to a biological and predictive model, one that better reflects the mechanisms underlying ischemic events and may improve prevention strategies worldwide.”
Read the full article here.
Article: Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification
Authors: Luca Saba, Peter Libby

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Feb 18, 2026, 16:47Sophia Delicou: Importance of Assessing Hemoglobin Functional Capacity Rather Than Total Levels
-
Feb 18, 2026, 16:32Cheng-Hock Toh: 5 Steps to Transform Transfusion Practice
-
Feb 18, 2026, 16:26Tareq Abadl: CMV and Transfusion – Leukoreduction vs CMV-Seronegative
-
Feb 18, 2026, 16:24Soroush Sohrabi: The Hidden Biology of Sclerotherapy and Mechanisms Beyond Endothelial Injury
-
Feb 18, 2026, 16:23Hamad Abbasi: Why are Coronary Stents so Expensive?
-
Feb 18, 2026, 16:08Carlos Doti: AstraZeneca’s Expanding Impact in Blood Cancer Care
-
Feb 18, 2026, 16:05Shiny K. Kajal: Routine vs Massive Transfusion Protocol
-
Feb 18, 2026, 16:03Maria Farid: Successful Consultative Hematology and Transfusion Medicine Workshop at PKLI
-
Feb 18, 2026, 15:59Ella Lawson: Could Erythritol Harm the Brain’s Blood Vessels?